Practical Considerations Arising from the Implementation of Lung Stereotactic Body Radiation Therapy (SBRT) at a Comprehensive Cancer Center
Max R. Dahele, Shannon Pearson, Thomas G. Purdie et al. · Journal of Thoracic Oncology · 2008
Cited by 48 works. doi:10.1097/jto.0b013e31818b1771
Authors
- Max R. Dahele
- Shannon Pearson
- Thomas G. Purdie
- Jean‐Pierre Bissonnette
- K. Franks
- Anthony M. Brade
- John Cho
- Alexander Y. Sun
- Andrew J. Hope
- Andrea Marshall
- Jane Higgins
- Andrea Bezjak
References
- The stereotaxic method and radiosurgery of the brain.
- Excessive Toxicity When Treating Central Tumors in a Phase II Study of Stereotactic Body Radiation Therapy for Medically Inoperable Early-Stage Lung Cancer
- Stereotactic High Dose Fraction Radiation Therapy of Extracranial Tumors Using An Accelerator: Clinical experience of the first thirty-one patients
- Extracranial Stereotactic Radioablation *
- Hypofractionated Stereotactic Radiotherapy (HypoFXSRT) for Stage I Non-small Cell Lung Cancer: Updated Results of 257 Patients in a Japanese Multi-institutional Study
- Focal, high dose, and fractionated modified stereotactic radiation therapy for lung carcinoma patients
- Outcomes of Risk-Adapted Fractionated Stereotactic Radiotherapy for Stage I Non–Small-Cell Lung Cancer
- Radiotherapy Alone for Medically Inoperable Stage I Non-Small–Cell Lung Cancer: The Duke Experience
- American Society for Therapeutic Radiology and Oncology (ASTRO) and American College of Radiology (ACR) Practice Guideline for the Performance of Stereotactic Body Radiation Therapy
- Stereotactic radiotherapy for primary lung cancer and pulmonary metastases: A noninvasive treatment approach in medically inoperable patients